Appendix Table A2.
Treatment over time among NSTEMI patients age 60–79 years (N = 65,621 in the UK; N = 66,968 in the US), by country, N (%).
| Admission year | 2007 | 2008 | 2009 | 2010 | 2007–10 | |
|---|---|---|---|---|---|---|
| Received in-hospital angiography | MINAP (UK) | 26.3 | 32.7 | 40.5 | 44.3 | 36.5 |
| RIKS-HIA (Sweden) | 74.0 | 78.0 | 81.9 | 83.1 | 79.1 | |
| ACTION (US) | 77.4 | 80.1 | 82.2 | 82.8 | 81.0 | |
| Received in-hospital PCI | MINAP (UK) | 18.7 | 23.0 | 25.9 | 29.1 | 24.5 |
| RIKS-HIA (Sweden) | 46.1 | 48.6 | 51.2 | 53.8 | 49.9 | |
| ACTION (US) | 42.8 | 43.5 | 45.2 | 45.9 | 44.6 | |
| Received dual antiplatelet at discharge | MINAP (UK) | 76.6 | 76.6 | 78.7 | 81.1 | 78.4 |
| RIKS-HIA (Sweden) | 66.6 | 70.7 | 73.7 | 75.3 | 71.5 | |
| ACTION (US) | 65.0 | 65.1 | 66.9 | 68.3 | 66.7 | |
| Received single antiplatelet at discharge | MINAP (UK) | 17.9 | 17.9 | 16.6 | 15.1 | 16.8 |
| RIKS-HIA (Sweden) | 26.5 | 23.6 | 21.5 | 19.4 | 22.9 | |
| ACTION (US) | 30.7 | 30.5 | 29.4 | 28.0 | 29.4 | |
| Received beta blocker at discharge | MINAP (UK) | 74.1 | 76.5 | 77.8 | 79.6 | 77.2 |
| RIKS-HIA (Sweden) | 88.4 | 89.0 | 88.9 | 89.3 | 88.9 | |
| ACTION (US) | 91.0 | 89.9 | 89.5 | 89.7 | 90.0 | |
| Received ACEI or ARB at discharge | MINAP (UK) | 80.3 | 80.9 | 82.0 | 83.9 | 81.9 |
| RIKS-HIA (Sweden) | 68.5 | 71.7 | 74.7 | 76.3 | 72.7 | |
| ACTION (US) | 67.5 | 66.5 | 66.2 | 65.6 | 66.3 | |
| Received statin at discharge | MINAP (UK) | 93.4 | 93.4 | 93.6 | 94.1 | 93.7 |
| RIKS-HIA (Sweden) | 87.0 | 89.1 | 90.1 | 90.3 | 89.1 | |
| ACTION (US) | 83.7 | 85.4 | 87.0 | 87.3 | 86.1 | |